Citation

Amita Gupta, Grace Montepiedra, Lisa Aaron, Gerhard Theron , Katie McCarthy , Sarah Bradford , Tsungai Chipato, Tichaona Vhembo, Lynda Stranix-Chibanda, Carolyne Onyango-Makumbi, Gaerolwe R Masheto , Avy Violari, Blandina T Mmbaga, Linda Aurpibul, Ramesh Bhosale, Vidya Mave , Vanessa Rouzier, Anneke Hesseling, Katherine Shin, Bonnie Zimmer, Diane Costello, Timothy R Sterling, Nahida Chakhtoura, Patrick Jean-Philippe, Adriana Weinberg, IMPAACT P1078 TB APPRISE Study Team. Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. New England Journal of Medicine. 2019 Oct 03; 381(14):1333-1346. PMID: 31577875; PMCID: PMC7051859.

Citation

C Onyango-Makumbi, AH Owora, RS Mwiru, A Mwatha, AM Young, D Moodley, HM Coovadia, L Staranix-Chibanda, K Manji, Y Maldonado, P Richardson, P Andrew, K George, W Fawzi, MG Fowler. Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants. Journal of Acquired Immune Deficiency Syndromes. 2019 Dec 01; 82(4):377-385. PMID: 31567725; PMCID: PMC6817404.

Citation

Diana F Clarke, Mark Mirochnick, Edward P Acosta, Edmund Capparelli, Anne Chain, Hedy Teppler, Betsy Smith, Jos Lommerse, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1110 Study Team. Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110. Journal of Acquired Immune Deficiency Syndromes. 2019 Dec 01; 82(4):392-398. PMID: 31658182; PMCID: PMC6820708.

Citation

T Meyers, P Samson, EP Acosta, J Moye, E Townley, S Bradford, L Marillo, K Denson, L Hovind, T Sise, H Teppler, SR Mathiba, A Hesseling, MF Cotton, P Krogstad, IMPAACT P1101 Team. Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. AIDS. 2019 Nov 15; 15(33):2197-2203. PMID: 31689263; PMCID: PMC7232968.

Citation

Catherine N Le, Paul Britto, Sean S Brummel, Risa M Hoffman, Jonathan Z Li, Patricia M Flynn, Taha E Taha, Anne Coletti, Mary Glenn Fowler, Ronald J Bosch, Rajesh T Gandhi, Karin L Klingman, James A McIntyre, Judith S Currier. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men. AIDS. 2019 Nov 15; 33(14):2149-2156. PMID: 31373919; PMCID: PMC6832824.

Citation

Kartik Kailas Venkatesh, Mona Farhad, Terry Fenton, Dhayendre Moodley, Shilpa Naik, Clemensia Nakabiito, Lee Fairlie, Mary Glenn Fowler, Jeffrey S A Stringer, Benjamin H Chi. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis. AIDS. 2019 Dec 01; 33(15):2403-2413. PMID: 31764105; PMCID: PMC7293898.

Citation

J Lommerse, D Clarke, T Kerbusch, H Merdjan, H Witjes, H Teppler, M Mirochnick, EP Acosta, L Wenning, S Nachman, A Chain. Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing. CPT: pharmacometrics & systems pharmacology. 2019 Sep 05; 8(9):643-653. PMID: 31215170; PMCID: PMC6765695.

Citation

Stein Schalkwijk, Rob Ter Heine, Angela Colbers, Edmund Capparelli, Brookie M Best, Tim R Cressey, Rick Greupink, Frans G M Russel, José Moltó, Mark Mirochnick, Mats O Karlsson, David M Burger. Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling. Journal of Antimicrobial Chemotherapy. 2019 May 01; 74(5):1348-1356. PMID: 30715324; PMCID: PMC6477987.

Citation

Patricia M Flynn, Taha E Taha, Mae Cababasay, Mary Glenn Fowler, Lynne Mofenson, Mazensia Owor, Susan Fiscus, Lynda Stranix-Chibanda, Anna Coutsoudis, Devasena Gnanashanmugam, Nahida Chakhtoura, Katie McCarthy, Cornelius Mukuzunga, Bonus Makanani, Dhayendre Moodley, Teacler Nematadzira, Bangini Kusakara, Sandesh Patil, Tichaona Vhembo, Raziya Bobat, Blandina Mmaga, Maysseb Masenya, Mandisa Nyati, Gerhard Theron, Helen Mulenga, David E Shapiro, The PROMISE Team. Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial. Journal of Acquired Immune Deficiency Syndromes. 2018 Apr 01; 77(4):383-392. PMID: 29239901; PMCID: PMC5825265.

Citation

K Adachi, J Xu, N Yeganeh, M Camarca, MG Morgado, DH Watts, LM Mofenson, VG Veloso, JH Pilotto, E Joao, G Gray, G Theron, B Santos, R Fonseca, R Kreitchmann, J Pinto, MM Mussi-Pinhata, DM Machado, YJ Bryson, B Grinsztejn, J Move, JD Klausner, CC Bristow, R Dickover, M Mirochnick, K Nielsen-Saines, HPTN 040 Study Team. Combined Evaluation of Sexually Transmitted Infections in HIV-infected Pregnant Women and Infant HIV Transmission. PLoS One. 2018 Jan 05; 13(1):e0189851. PMID: 29304083.